Is Know Labs, Inc. overvalued or undervalued?

As of 14 February 2023, the valuation grade for Know Labs, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its financial health. The company is currently considered overvalued given its negative financial ratios, including a P/E ratio of NA due to losses, a price to book value of -1.99, and an EV to EBITDA of -1.38. These figures suggest that the company is struggling to generate positive returns and is not in a position to justify its current valuation.
In comparison to its peers, Know Labs, Inc. stands out negatively, particularly against Vuzix Corp., which has a P/E of -5.47, and Profire Energy, Inc., which is attractive with a P/E of 14.05. The stark contrast in valuation metrics highlights the challenges Know Labs faces in the market. Additionally, the company's stock has significantly underperformed relative to the S&P 500, with a one-year return of -87.04% compared to the index's 10.26%. Overall, Know Labs, Inc. is overvalued based on its current financial metrics and peer comparisons.